These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28281571)

  • 21. A Novel Mutation of
    D Hidalgo-Santos A; Del Carmen DeMingo-Alemany M; Moreno-Macián F; Roselló M; Orellana C; Martínez F; Caro-Llopis A; León-Cariñena S; Tomás-Vila M
    Int J Endocrinol Metab; 2018 Jul; 16(3):e67329. PubMed ID: 30323850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two mouse models carrying truncating mutations in Magel2 show distinct phenotypes.
    Ieda D; Negishi Y; Miyamoto T; Johmura Y; Kumamoto N; Kato K; Miyoshi I; Nakanishi M; Ugawa S; Oishi H; Saitoh S
    PLoS One; 2020; 15(8):e0237814. PubMed ID: 32804975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of obesity in the fatal outcome of Schaaf-Yang syndrome: Early onset morbid obesity in a patient with a MAGEL2 mutation.
    Kleinendorst L; Pi Castán G; Caro-Llopis A; Boon EMJ; van Haelst MM
    Am J Med Genet A; 2018 Nov; 176(11):2456-2459. PubMed ID: 30238631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis of Schaaf-Yang syndrome in Korean children with developmental delay and hypotonia.
    Ahn H; Seo GH; Oh A; Lee Y; Keum C; Heo SH; Kim T; Choi J; Kim GH; Ko TS; Yum MS; Lee BH; Choi IH
    Medicine (Baltimore); 2020 Dec; 99(51):e23864. PubMed ID: 33371171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A De Novo FOXP1 Truncating Mutation in a Patient Originally Diagnosed as C Syndrome.
    Urreizti R; Damanti S; Esteve C; Franco-Valls H; Castilla-Vallmanya L; Tonda R; Cormand B; Vilageliu L; Opitz JM; Neri G; Grinberg D; Balcells S
    Sci Rep; 2018 Jan; 8(1):694. PubMed ID: 29330474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal analysis of electroencephalography pattern changes in an infant with Schaaf-Yang syndrome and a novel mutation in melanoma antigen L2 (MAGEL2).
    Mizuno S; Yokoyama K; Yokoyama A; Nukata T; Ikeda Y; Hara S
    Mol Genet Genomic Med; 2022 Jun; 10(6):e1932. PubMed ID: 35343647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compound heterozygous mutations in the IFT140 gene cause Opitz trigonocephaly C syndrome in a patient with typical features of a ciliopathy.
    Peña-Padilla C; Marshall CR; Walker S; Scherer SW; Tavares-Macías G; Razo-Jiménez G; Bobadilla-Morales L; Acosta-Fernández E; Corona-Rivera A; Mendoza-Londono R; Corona-Rivera JR
    Clin Genet; 2017 Apr; 91(4):640-646. PubMed ID: 27874174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MAGEL2-related disorders: A study and case series.
    Patak J; Gilfert J; Byler M; Neerukonda V; Thiffault I; Cross L; Amudhavalli S; Pacio-Miguez M; Palomares-Bralo M; Garcia-Minaur S; Santos-Simarro F; Powis Z; Alcaraz W; Tang S; Jurgens J; Barry B; England E; Engle E; Hess J; Lebel RR
    Clin Genet; 2019 Dec; 96(6):493-505. PubMed ID: 31397880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advancing in Schaaf-Yang syndrome pathophysiology: from bedside to subcellular analyses of truncated MAGEL2.
    Castilla-Vallmanya L; Centeno-Pla M; Serrano M; Franco-Valls H; Martínez-Cabrera R; Prat-Planas A; Rojano E; Ranea JAG; Seoane P; Oliva C; Paredes-Fuentes AJ; Marfany G; Artuch R; Grinberg D; Rabionet R; Balcells S; Urreizti R
    J Med Genet; 2023 Apr; 60(4):406-415. PubMed ID: 36243518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magel2 Modulates Bone Remodeling and Mass in Prader-Willi Syndrome by Affecting Oleoyl Serine Levels and Activity.
    Baraghithy S; Smoum R; Drori A; Hadar R; Gammal A; Hirsch S; Attar-Namdar M; Nemirovski A; Gabet Y; Langer Y; Pollak Y; Schaaf CP; Rech ME; Gross-Tsur V; Bab I; Mechoulam R; Tam J
    J Bone Miner Res; 2019 Jan; 34(1):93-105. PubMed ID: 30347474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Magel2 truncation alters select behavioral and physiological outcomes in a rat model of Schaaf-Yang syndrome.
    Reznik DL; Yang MV; Albelda de la Haza P; Jain A; Spanjaard M; Theiss S; Schaaf CP; Malovannaya A; Strong TV; Veeraragavan S; Samaco RC
    Dis Model Mech; 2023 Feb; 16(2):. PubMed ID: 36637363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opitz trigonocephaly C syndrome in a boy with a de novo balanced reciprocal translocation t(3;18)(q13.13;q12.1).
    Chinen Y; Kaname T; Yanagi K; Saito N; Naritomi K; Ohta T
    Am J Med Genet A; 2006 Aug; 140(15):1655-7. PubMed ID: 16835930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early onset critically ill infants with Schaaf-Yang syndrome: a retrospective study from the China neonatal genomes project and literature review.
    Huang Z; Lu W; Zhang P; Lu Y; Chen L; Kang W; Yang L; Li G; Zhu J; Wu B; Zhou W; Wang H
    Ann Transl Med; 2023 Jun; 11(9):312. PubMed ID: 37404980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic testing and PGD for unexplained recurrent fetal malformations with MAGEL2 gene mutation.
    Guo W; Nie Y; Yan Z; Zhu X; Wang Y; Guan S; Kuo Y; Zhang W; Zhi X; Wei Y; Yan L; Qiao J
    Sci China Life Sci; 2019 Jul; 62(7):886-894. PubMed ID: 31152388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A MAGEL2-deubiquitinase complex modulates the ubiquitination of circadian rhythm protein CRY1.
    Carias KV; Zoeteman M; Seewald A; Sanderson MR; Bischof JM; Wevrick R
    PLoS One; 2020; 15(4):e0230874. PubMed ID: 32315313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. De novo nonsense mutations in ASXL1 cause Bohring-Opitz syndrome.
    Hoischen A; van Bon BW; Rodríguez-Santiago B; Gilissen C; Vissers LE; de Vries P; Janssen I; van Lier B; Hastings R; Smithson SF; Newbury-Ecob R; Kjaergaard S; Goodship J; McGowan R; Bartholdi D; Rauch A; Peippo M; Cobben JM; Wieczorek D; Gillessen-Kaesbach G; Veltman JA; Brunner HG; de Vries BB
    Nat Genet; 2011 Jun; 43(8):729-31. PubMed ID: 21706002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two novel patients with Bohring-Opitz syndrome caused by de novo ASXL1 mutations.
    Magini P; Della Monica M; Uzielli ML; Mongelli P; Scarselli G; Gambineri E; Scarano G; Seri M
    Am J Med Genet A; 2012 Apr; 158A(4):917-21. PubMed ID: 22419483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early-onset epileptic encephalopathy and severe developmental delay in an association with de novo double mutations in
    Akamine S; Sagata N; Sakai Y; Kato TA; Nakahara T; Matsushita Y; Togao O; Hiwatashi A; Sanefuji M; Ishizaki Y; Torisu H; Saitsu H; Matsumoto N; Hara T; Sawa A; Kano S; Furue M; Kanba S; Shaw CA; Ohga S
    Epilepsia Open; 2018 Mar; 3(1):81-85. PubMed ID: 29588991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extending the phenotypic spectrum of Bohring-Opitz syndrome: Mild case confirmed by functional studies.
    Leon E; Diaz J; Castilla-Vallmanya L; Grinberg D; Balcells S; Urreizti R
    Am J Med Genet A; 2020 Jan; 182(1):201-204. PubMed ID: 31692235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exome sequencing identifies a de novo SCN2A mutation in a patient with intractable seizures, severe intellectual disability, optic atrophy, muscular hypotonia, and brain abnormalities.
    Baasch AL; Hüning I; Gilissen C; Klepper J; Veltman JA; Gillessen-Kaesbach G; Hoischen A; Lohmann K
    Epilepsia; 2014 Apr; 55(4):e25-9. PubMed ID: 24579881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.